Open AccessLevocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia
Author(s) -
Takashi Maruyama,
Terumi Higuchi,
Toshio Yamazaki,
Erina Okawa,
Hideyuki Ando,
Osamu Oikawa,
Atsushi Inoshita,
Kazuyoshi Okada,
Masanori Abe
Publication year - 2017
Publication title -
cardiorenal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 21
eISSN - 1664-3828
pISSN - 1664-5502
DOI - 10.1159/000462983
Subject(s) - medicine , erythropoiesis , hemodialysis , anemia , levocarnitine , erythropoietin , intensive care medicine , pharmacology , endocrinology , carnitine
The aim of this study was to evaluate the efficacy of levocarnitine injection for renal anemia in hemodialysis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom